The stock is currently fairly valued at a price-to-earnings ratio of 24.19, supported by strong fundamentals including a 22.54% net profit margin, 44.88% return on equity, and consistently positive free cash flow, underscoring a resilient and efficiently managed business. Revenue grew 3.21% year-over-year, reflecting steady performance amid a mature market, while the company’s diversified portfolio and global brand strength enable premium pricing and stable demand. However, the single biggest risk lies in shifting consumer preferences toward healthier alternatives, threatening core sugary drink sales amid intensifying competition and rising regulatory scrutiny—particularly around sugar taxes and health-related marketing restrictions—while moderate leverage (debt-to-equity of 1.78) adds sensitivity to rising interest rates.